Takeda Pharmaceutical Company Ltd
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- -
- Established
- 1925-01-01
- Employees
- -
- Market Cap
- $47.5B
- Website
- http://www.takeda.co.jp/
Safety of Ramelteon in Elderly Subjects
Phase 4
Completed
- Conditions
- Insomnia
- Interventions
- Drug: Ramelteon, zolpidem and placebo
- First Posted Date
- 2007-12-06
- Last Posted Date
- 2012-02-28
- Lead Sponsor
- Takeda
- Target Recruit Count
- 33
- Registration Number
- NCT00568789
Efficacy of Lapaquistat Acetate Co-Administered With Statins in Subjects With Hypercholesterolemia
Phase 3
Terminated
- Conditions
- Hypercholesterolemia
- Interventions
- Drug: Stable statin therapy
- First Posted Date
- 2007-09-20
- Last Posted Date
- 2016-06-22
- Lead Sponsor
- Takeda
- Target Recruit Count
- 411
- Registration Number
- NCT00532311
Efficacy of Lapaquistat Acetate on Blood Cholesterol Levels in Treating Subjects With Hypercholesterolemia
- First Posted Date
- 2007-09-20
- Last Posted Date
- 2012-05-24
- Lead Sponsor
- Takeda
- Target Recruit Count
- 657
- Registration Number
- NCT00532558
Safety Comparison of Pioglitazone and Glyburide in Type 2 Diabetes Subjects With Mild to Moderate Congestive Heart Failure
- First Posted Date
- 2007-08-28
- Last Posted Date
- 2012-02-28
- Lead Sponsor
- Takeda
- Target Recruit Count
- 518
- Registration Number
- NCT00521820
Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac Disease
- First Posted Date
- 2007-08-28
- Last Posted Date
- 2012-02-28
- Lead Sponsor
- Takeda
- Target Recruit Count
- 300
- Registration Number
- NCT00521742
MPC-004 for the Treatment of an Acute Gout Flare
Phase 3
Completed
- Conditions
- Gout
- Interventions
- Drug: High Dose Colchicine (4.8 mg total dose)Drug: Low Dose Colchicine (1.8mg total dose)Other: Placebo Control
- First Posted Date
- 2007-07-25
- Last Posted Date
- 2012-11-01
- Lead Sponsor
- Takeda
- Target Recruit Count
- 185
- Registration Number
- NCT00506883
- Locations
- 🇺🇸
Medical Research Trust, Lake Worth, Florida, United States
🇺🇸Bond Clinic, Winter Haven, Florida, United States
🇺🇸Jacksonville Center for Clinical Research, Jacksonville, Florida, United States
Safety Study of Pioglitazone Compared To Glyburide on Liver Function
- First Posted Date
- 2007-06-29
- Last Posted Date
- 2012-02-28
- Lead Sponsor
- Takeda
- Target Recruit Count
- 2120
- Registration Number
- NCT00494312
Efficacy of Ramelteon on Insomnia Symptoms Associated With Jet Lag in Healthy Adult Volunteers
- First Posted Date
- 2007-06-27
- Last Posted Date
- 2012-02-28
- Lead Sponsor
- Takeda
- Target Recruit Count
- 110
- Registration Number
- NCT00492011
Facilitation of Zolpidem (≥10 mg) Discontinuation Through Use of Ramelteon in Subjects With Chronic Insomnia
Phase 4
Completed
- Conditions
- Chronic Insomnia
- Interventions
- First Posted Date
- 2007-06-27
- Last Posted Date
- 2010-07-20
- Lead Sponsor
- Takeda
- Target Recruit Count
- 135
- Registration Number
- NCT00492232
Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary Dyslipidemia
Phase 3
Completed
- Conditions
- Dyslipidemia
- Interventions
- First Posted Date
- 2007-06-19
- Last Posted Date
- 2012-05-24
- Lead Sponsor
- Takeda
- Target Recruit Count
- 2130
- Registration Number
- NCT00487994
© Copyright 2025. All Rights Reserved by MedPath